bf/NASDAQ:JNCE_icon.jpeg

NASDAQ:JNCE

Jounce Therapeutics, Inc.

  • Stock

USD

Last Close

1.88

03/05 20:00

Market Cap

98.95M

Beta: 0.75

Volume Today

11.60M

Avg: 3.15M

PE Ratio

−1.91

PFCF: −3.32

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-10.52M
-
-28.53M
171.32%
-13.70M
51.97%
-16.44M
20.00%
-27.38M
66.51%
56.82M
307.54%
-43.84M
177.16%
-90.87M
107.27%
-50.92M
43.97%
depreciation and amortization
1.11M
-
1.47M
32.91%
1.94M
32.24%
4.42M
127.47%
3.83M
13.36%
3.85M
0.52%
3.40M
11.69%
2.83M
16.88%
2.09M
26.18%
deferred income tax
stock based compensation
332K
-
1.35M
307.23%
4.99M
269.01%
4.78M
4.29%
9.41M
97.01%
9.61M
2.15%
9.77M
1.69%
11.48M
17.46%
10.27M
10.49%
change in working capital
-320K
-
1.83M
671.88%
186.13M
10,071.09%
-84.74M
145.53%
-48.37M
42.92%
-98.93M
104.55%
2.83M
102.87%
-7.85M
376.79%
8.88M
213.19%
accounts receivables
inventory
accounts payables
-301K
-
673K
323.59%
-312K
146.36%
373K
219.55%
562K
50.67%
-944K
267.97%
-296K
68.64%
-329K
11.15%
421K
227.96%
other working capital
-19K
-
1.16M
6,189.47%
186.44M
16,014.35%
-85.11M
145.65%
-48.93M
42.51%
-97.99M
100.27%
3.13M
103.20%
-7.52M
340.11%
8.46M
212.54%
other non cash items
-5.51M
-
-1.86M
66.27%
327K
117.59%
1.25M
281.35%
-1.11M
188.77%
-1.48M
33.69%
47K
103.18%
921K
1,859.57%
800K
13.14%
net cash provided by operating activities
-14.91M
-
-25.74M
72.64%
179.69M
798.12%
-90.74M
150.50%
-63.61M
29.89%
-30.13M
52.64%
-27.79M
7.77%
-83.49M
200.47%
-28.88M
65.41%
investments in property plant and equipment
-699K
-
-2.20M
215.02%
-2.22M
0.91%
-15.11M
579.88%
-1.36M
91.00%
-985K
27.52%
-94K
90.46%
-373K
296.81%
-919K
146.38%
acquisitions net
purchases of investments
-213.29M
-
-179.87M
15.67%
-252.92M
40.61%
-189.00M
25.27%
-85.89M
54.55%
-130.27M
51.66%
-24.93M
80.86%
sales maturities of investments
156.96M
-
340.69M
117.06%
221.37M
35.02%
137.29M
37.98%
70.13M
48.92%
109.33M
55.89%
other investing activites
-10K
-
60K
700%
net cash used for investing activites
-709K
-
-2.14M
202.12%
-215.51M
9,961.06%
-38.02M
82.36%
86.41M
327.28%
31.38M
63.68%
51.30M
63.46%
-60.51M
217.97%
83.48M
237.95%
debt repayment
common stock issued
22K
-
112K
409.09%
50K
55.36%
107.01M
213,916%
3.65M
-
70.14M
1,824.33%
90.83M
29.49%
442K
99.51%
common stock repurchased
55.73M
-
dividends paid
other financing activites
14.98M
-
70.59M
371.12%
35.46M
49.77%
462K
98.70%
1.55M
234.63%
437K
71.73%
-55.13M
12,715.56%
1.22M
102.21%
net cash used provided by financing activities
15.01M
-
70.70M
371.17%
35.51M
49.78%
107.47M
202.67%
1.55M
98.56%
4.08M
164.04%
70.74M
1,633.02%
92.04M
30.11%
442K
99.52%
effect of forex changes on cash
net change in cash
-612K
-
42.82M
7,097.22%
-313K
100.73%
-21.29M
6,701.60%
24.35M
214.36%
5.33M
78.09%
94.25M
1,666.67%
-51.96M
155.13%
55.04M
205.93%
cash at beginning of period
2.95M
-
2.34M
20.75%
45.16M
1,831.61%
44.85M
0.69%
24.83M
44.64%
49.18M
98.06%
54.51M
10.85%
148.76M
172.90%
96.80M
34.93%
cash at end of period
2.34M
-
45.16M
1,831.61%
44.85M
0.69%
23.56M
47.47%
49.18M
108.74%
54.51M
10.85%
148.76M
172.90%
96.80M
34.93%
151.84M
56.86%
operating cash flow
-14.91M
-
-25.74M
72.64%
179.69M
798.12%
-90.74M
150.50%
-63.61M
29.89%
-30.13M
52.64%
-27.79M
7.77%
-83.49M
200.47%
-28.88M
65.41%
capital expenditure
-699K
-
-2.20M
215.02%
-2.22M
0.91%
-15.11M
579.88%
-1.36M
91.00%
-985K
27.52%
-94K
90.46%
-373K
296.81%
-919K
146.38%
free cash flow
-15.61M
-
-27.94M
79.02%
177.47M
735.15%
-105.84M
159.64%
-64.97M
38.62%
-31.11M
52.11%
-27.88M
10.39%
-83.87M
200.79%
-29.80M
64.47%

All numbers in USD (except ratios and percentages)